BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sukocheva OA, Furuya H, Ng ML, Friedemann M, Menschikowski M, Tarasov VV, Chubarev VN, Klochkov SG, Neganova ME, Mangoni AA, Aliev G, Bishayee A. Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target. Pharmacol Ther 2020;207:107464. [PMID: 31863815 DOI: 10.1016/j.pharmthera.2019.107464] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Chen S, Xiang H, Liang Z, Lu H. Role of sphingosine-1-phosphate receptors in vascular injury of inflammatory bowel disease. J Cell Mol Med 2021;25:2740-9. [PMID: 33595873 DOI: 10.1111/jcmm.16333] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Ishay Y, Rotnemer-Golinkin D, Ilan Y. The role of the sphingosine axis in immune regulation: A dichotomy in the anti-inflammatory effects between sphingosine kinase 1 and sphingosine kinase 2-dependent pathways. Int J Immunopathol Pharmacol 2021;35:20587384211053274. [PMID: 34789044 DOI: 10.1177/20587384211053274] [Reference Citation Analysis]
3 Hao Y, Zhang R, Morris R, Cheng F, Zhu Z, Xu Y, Wang Y. Metabolome and microbiome alterations in tongue coating of gastric precancerous lesion patients. Expert Rev Gastroenterol Hepatol 2021;15:949-63. [PMID: 33252275 DOI: 10.1080/17474124.2021.1850259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Adams DR, Pyne S, Pyne NJ. Structure-function analysis of lipid substrates and inhibitors of sphingosine kinases. Cell Signal 2020;76:109806. [PMID: 33035646 DOI: 10.1016/j.cellsig.2020.109806] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Alhouayek M, Ameraoui H, Muccioli GG. Bioactive lipids in inflammatory bowel diseases - From pathophysiological alterations to therapeutic opportunities. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158854. [PMID: 33157277 DOI: 10.1016/j.bbalip.2020.158854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pérez-Jeldres T, Alvarez-Lobos M, Rivera-Nieves J. Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis. Drugs 2021;81:985-1002. [PMID: 33983615 DOI: 10.1007/s40265-021-01528-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Pyne NJ, Pyne S. Recent advances in the role of sphingosine 1-phosphate in cancer. FEBS Lett 2020;594:3583-601. [PMID: 32969034 DOI: 10.1002/1873-3468.13933] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
8 Shi Y, Wei Q, Liu Y, Yuan J. The alleviating effect of sphingosine kinases 2 inhibitor K145 on nonalcoholic fatty liver. Biochem Biophys Res Commun 2021;580:1-6. [PMID: 34607257 DOI: 10.1016/j.bbrc.2021.09.060] [Reference Citation Analysis]
9 Wu JN, Lin L, Luo SB, Qiu XZ, Zhu LY, Chen D, Wei ED, Fu ZH, Qin MB, Liang ZH, Huang JA, Liu SQ. SphK1-driven autophagy potentiates focal adhesion paxillin-mediated metastasis in colorectal cancer. Cancer Med 2021;10:6010-21. [PMID: 34268882 DOI: 10.1002/cam4.4129] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Qin H, Li M, Xie G, Cao W, Xu D, Zhao H, Fu L, J. L. F. Associations among S100A4, Sphingosine-1-Phosphate, and Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease. Oxidative Medicine and Cellular Longevity 2022;2022:1-10. [DOI: 10.1155/2022/6041471] [Reference Citation Analysis]
11 Wei LQ, Tan JC, Wang Y, Mei YK, Xue JY, Tian L, Song KY, Han L, Cui YC, Peng YB, Li JQ, Liu NN, Wang H. Fingolimod Potentiates the Antifungal Activity of Amphotericin B. Front Cell Infect Microbiol 2021;11:627917. [PMID: 33968796 DOI: 10.3389/fcimb.2021.627917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ding T, Chen H, Li Y, Li Y, Zhi Y, Qu Z, Sun Q, Yao Q, Liu B. Discovery of an SphK1 inhibitor: A hybrid approach involving a receptor–ligand-complex-based pharmacophore and docking-based virtual screening. Journal of Chemical Research 2022;46:174751982210892. [DOI: 10.1177/17475198221089222] [Reference Citation Analysis]
13 Weidle UH, Birzele F, Brinkmann U, Auslaender S. Gastric Cancer: Identification of microRNAs Inhibiting Druggable Targets and Mediating Efficacy in Preclinical In Vivo Models. Cancer Genomics Proteomics 2021;18:497-514. [PMID: 34183383 DOI: 10.21873/cgp.20275] [Reference Citation Analysis]
14 Wang H, Zhao B, Bian E, Zong G, He J, Wang Y, Ma C, Wan J. Ubiquitination Destabilizes Protein Sphingosine Kinase 2 to Regulate Glioma Malignancy. Front Cell Neurosci 2021;15:660354. [PMID: 34305532 DOI: 10.3389/fncel.2021.660354] [Reference Citation Analysis]
15 Zeng Z, Ma C, Chen K, Jiang M, Vasu R, Liu R, Zhao Y, Zhang H. Roles of G Protein-Coupled Receptors (GPCRs) in Gastrointestinal Cancers: Focus on Sphingosine 1-Shosphate Receptors, Angiotensin II Receptors, and Estrogen-Related GPCRs. Cells 2021;10:2988. [PMID: 34831211 DOI: 10.3390/cells10112988] [Reference Citation Analysis]
16 Hengst JA, Nduwumwami AJ, Raup-Konsavage WM, Vrana KE, Yun JK. Inhibition of Sphingosine Kinase Activity Enhances Immunogenic Cell Surface Exposure of Calreticulin Induced by the Synthetic Cannabinoid 5-epi-CP-55,940. Cannabis Cannabinoid Res 2021. [PMID: 34846947 DOI: 10.1089/can.2021.0100] [Reference Citation Analysis]
17 Li HH, Lin YT, Laiakis EC, Goudarzi M, Weber W, Fornace AJ Jr. Serum Metabolomic Alterations Associated with Cesium-137 Internal Emitter Delivered in Various Dose Rates. Metabolites 2020;10:E270. [PMID: 32629836 DOI: 10.3390/metabo10070270] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Ding T, Zhi Y, Xie W, Yao Q, Liu B. Rational design of SphK inhibitors using crystal structures aided by computer. Eur J Med Chem 2021;213:113164. [PMID: 33454547 DOI: 10.1016/j.ejmech.2021.113164] [Reference Citation Analysis]
19 Patel DS, Ahmad F, Abu Sneineh M, Patel RS, Rohit Reddy S, Llukmani A, Hashim A, Gordon DK. The Importance of Sphingosine Kinase in Breast Cancer: A Potential for Breast Cancer Management. Cureus 2021;13:e13413. [PMID: 33758708 DOI: 10.7759/cureus.13413] [Reference Citation Analysis]
20 Sun M, Wang Q, Zhang M, Zhang G, Wu T, Liu R, Sui W, Zhang J, Yin J, Zhang M. Leuconostoc pseudomesenteroides improves microbiota dysbiosis and liver metabolism imbalance and ameliorates the correlation between dihydroceramide and strains of Firmicutes and Proteobacteria in high fat diet obese mice. Food Funct 2020;11:6855-65. [PMID: 32666978 DOI: 10.1039/d0fo01009j] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Xu Y, Zhang R, Morris R, Cheng F, Wang Y, Zhu Z, Hao Y. Metabolite Characteristics in Tongue Coating from Damp Phlegm Pattern in Patients with Gastric Precancerous Lesion. Evid Based Complement Alternat Med 2021;2021:5515325. [PMID: 34122594 DOI: 10.1155/2021/5515325] [Reference Citation Analysis]
22 Zhong L, Xie L, Yang Z, Li L, Song S, Cao D, Liu Y. Prognostic value of S1PR1 and its correlation with immune infiltrates in breast and lung cancers. BMC Cancer 2020;20:766. [PMID: 32799825 DOI: 10.1186/s12885-020-07278-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
23 Ala M, Ala M. Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next? ACS Pharmacol Transl Sci 2021;4:1747-70. [PMID: 34927008 DOI: 10.1021/acsptsci.1c00167] [Reference Citation Analysis]
24 Gomez-Larrauri A, Das Adhikari U, Aramburu-Nuñez M, Custodia A, Ouro A. Ceramide Metabolism Enzymes-Therapeutic Targets against Cancer. Medicina (Kaunas) 2021;57:729. [PMID: 34357010 DOI: 10.3390/medicina57070729] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Bu Y, Wu H, Deng R, Wang Y. Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases. Front Pharmacol 2021;12:733387. [PMID: 34737701 DOI: 10.3389/fphar.2021.733387] [Reference Citation Analysis]
26 Tang Y, Plötz T, Gräler MH, Gurgul-Convey E. Sphingosine-1 Phosphate Lyase Regulates Sensitivity of Pancreatic Beta-Cells to Lipotoxicity. Int J Mol Sci 2021;22:10893. [PMID: 34639233 DOI: 10.3390/ijms221910893] [Reference Citation Analysis]
27 Chubarev VN, Beeraka NM, Sinelnikov MY, Bulygin KV, Nikolenko VN, Mihaylenko E, Tarasov VV, Mikhaleva LM, Poltronieri P, Viswanadha VP, Somasundaram SG, Kirkland CE, Chen K, Liu J, Fan R, Kamal MA, Mironov AA, Madhunapantula SV, Pretorius E, Dindyaev SV, Muresanu C, Sukocheva OA. Health Science Community Will Miss This Bright and Uniting Star: In Memory of Professor Gjumrakch Aliev, M.D, Ph.D. Cancers (Basel) 2021;13:1965. [PMID: 33921833 DOI: 10.3390/cancers13081965] [Reference Citation Analysis]
28 Zhang K, Zhang L, Mi Y, Tang Y, Ren F, Liu B, Zhang Y, Zheng P. A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration. Cancer Sci 2020;111:4041-50. [PMID: 32860283 DOI: 10.1111/cas.14634] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
29 Miao YD, Mu LJ, Mi DH. Metabolism-associated genes in occurrence and development of gastrointestinal cancer: Latest progress and future prospect. World J Gastrointest Oncol 2021; 13(8): 758-771 [PMID: 34457185 DOI: 10.4251/wjgo.v13.i8.758] [Reference Citation Analysis]
30 Peng G, Zhu C, Sun Q, Li J, Chen Y, Guo Y, Ji H, Yang F, Dong W. Testicular miRNAs and tsRNAs provide insight into gene regulation during overwintering and reproduction of Onychostoma macrolepis. Fish Physiol Biochem 2022. [PMID: 35595880 DOI: 10.1007/s10695-022-01078-0] [Reference Citation Analysis]
31 Papakyriakou A, Cencetti F, Puliti E, Morelli L, Tricomi J, Bruni P, Compostella F, Richichi B. Glycans Meet Sphingolipids: Structure-Based Design of Glycan Containing Analogues of a Sphingosine Kinase Inhibitor. ACS Med Chem Lett 2020;11:913-20. [PMID: 32435405 DOI: 10.1021/acsmedchemlett.9b00665] [Reference Citation Analysis]
32 Wang J, Goren I, Yang B, Lin S, Li J, Elias M, Fiocchi C, Rieder F. The sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis: a unique therapeutic target in inflammatory bowel disease. Aliment Pharmacol Ther 2021. [PMID: 34932238 DOI: 10.1111/apt.16741] [Reference Citation Analysis]
33 Codini M, Garcia-Gil M, Albi E. Cholesterol and Sphingolipid Enriched Lipid Rafts as Therapeutic Targets in Cancer. Int J Mol Sci 2021;22:E726. [PMID: 33450869 DOI: 10.3390/ijms22020726] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
34 Zhang MY, Huo C, Liu JY, Shi ZE, Zhang WD, Qu JJ, Yue YL, Qu YQ. Identification of a Five Autophagy Subtype-Related Gene Expression Pattern for Improving the Prognosis of Lung Adenocarcinoma. Front Cell Dev Biol 2021;9:756911. [PMID: 34869345 DOI: 10.3389/fcell.2021.756911] [Reference Citation Analysis]
35 Hou CX, Wang L, Cai M, Meng Y, Tang YT, Zhu QH, Han W, Sun NN, Ma B, Hu Y, Ye JH. Sphk1 promotes salivary adenoid cystic carcinoma progression via PI3K/Akt signaling. Pathol Res Pract 2021;227:153620. [PMID: 34560416 DOI: 10.1016/j.prp.2021.153620] [Reference Citation Analysis]
36 Yang T, Wang X, Yuan Z, Miao Y, Wu Z, Chai Y, Yu Q, Wang H, Sun L, Huang X, Zhang L, Jiang Z. Sphingosine 1-phosphate receptor-1 specific agonist SEW2871 ameliorates ANIT-induced dysregulation of bile acid homeostasis in mice plasma and liver. Toxicol Lett 2020;331:242-53. [PMID: 32579994 DOI: 10.1016/j.toxlet.2020.06.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Cui K, Wu X, Gong L, Yao S, Sun S, Liu B, Zhou M, Yin Y, Huang Z. Comprehensive Characterization of Integrin Subunit Genes in Human Cancers. Front Oncol 2021;11:704067. [PMID: 34222028 DOI: 10.3389/fonc.2021.704067] [Reference Citation Analysis]
38 Potì F, Giorgio C, Zini I, Nofer JR, Vivo V, Palese S, Ballabeni V, Barocelli E, Bertoni S. Impact of S1P Mimetics on Mesenteric Ischemia/Reperfusion Injury. Pharmaceuticals (Basel) 2020;13:E298. [PMID: 33050288 DOI: 10.3390/ph13100298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Qu L, Shi K, Xu J, Liu C, Ke C, Zhan X, Xu K, Liu Y. Atractylenolide-1 targets SPHK1 and B4GALT2 to regulate intestinal metabolism and flora composition to improve inflammation in mice with colitis. Phytomedicine 2022;98:153945. [PMID: 35114452 DOI: 10.1016/j.phymed.2022.153945] [Reference Citation Analysis]